108 results match your criteria: "Makerere University Joint AIDS Program.[Affiliation]"

Background And Objectives: HIV testing is essential to access HIV treatment and care and plays a critical role in preventing transmission. Despite this, testing coverage is low among men in sub-Saharan Africa. Community-based testing has demonstrated potential to expand male testing coverage, yet scant evidence reveals how community-based services can be designed to optimize testing uptake.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) risk varies among different HIV subgroups, potentially impacting intensified case finding (ICF) performance. We evaluated the performance of the current ICF algorithm [symptom screening, followed by Xpert MTB/RIF (Xpert) testing] in 2 HIV subgroups and evaluated whether ICF performance could be improved if TB screening was based on C-reactive protein (CRP) concentrations.

Methods: We enrolled consecutive adults with CD4 counts ≤350 cells/µL initiating antiretroviral therapy and performed symptom screening, CRP testing using a low-cost point-of-care (POC) assay, and collected sputum for Xpert testing.

View Article and Find Full Text PDF

Background: Alcohol use is common among people living with HIV and particularly harmful during pregnancy. However, objective data on alcohol use in pregnant women living with HIV (WLWH) are lacking. In areas with high levels of alcohol use generally, such as South Africa and Uganda, these data are needed to inform interventions.

View Article and Find Full Text PDF

Background: Loss to follow-up (LTFU) from care among people living with HIV (PLHIV) is thought to be more common in the public setting compared to the private health care. It is anticipated that the problem may become worse with the current "test and treat" policy in Uganda due to the likely increases in patient loads and its attendant pressure on health care providers to support patient counseling. This study determined the incidence and factors associated with LTFU from HIV care among adult PLHIV in public health facilities in Wakiso district, Uganda.

View Article and Find Full Text PDF

Introduction: The success of universal antiretroviral therapy (ART) access and aspirations for an AIDS-free generation depend on high adherence in individuals initiating ART during early-stage HIV infection; however, adherence may be difficult in the absence of illness and associated support.

Methods: From March 2015 to October 2017, we prospectively observed three groups initiating ART in routine care in Uganda and South Africa: men and non-pregnant women with early-stage HIV infection (CD4 > 350 cells/μL), pregnant women with early-stage HIV infection and men and non-pregnant women with late-stage HIV infection (CD4 < 200 cells/μL). Socio-behavioural questionnaires were administered and viral loads were performed at 0, 6 and 12 months.

View Article and Find Full Text PDF

Closing the gap: A novel metric of change in performance.

East Afr J Appl Health Monitor Eval

February 2019

Department of Medicine, Division of HIV, ID and Global Medicine, University of California, San Francisco, USA.

Background: Interventions to improve performance of global programs in the HIV cascade of care are widespread and increasing the focus of implementation science. At present, however, there is no clear consensus on how to conceptualize their improvement at the program level. The commonly used measures of association, based on ratios of probabilities (or odds), have well-known defects in public health applications.

View Article and Find Full Text PDF

Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.

AIDS

April 2019

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.

Objectives: In resource-limited settings, mortality in the initial months following antiretroviral therapy (ART) initiation remains unacceptably high. Novel tools to identify patients at highest risk of poor outcomes are needed. We evaluated whether elevated C-reactive protein (CRP) concentrations predict poor outcomes among people living with HIV (PLWH) initiating ART.

View Article and Find Full Text PDF

Rationale: The recommended tuberculosis (TB) intensified case finding (ICF) algorithm for people living with HIV (symptom-based screening followed by Xpert MTB/RIF [Xpert] testing) is insufficiently sensitive and results in unnecessary Xpert testing.

Objectives: To evaluate whether novel ICF algorithms combining C-reactive protein (CRP)-based screening with urine Determine TB-LAM (TB-LAM), sputum Xpert, and/or sputum culture could improve ICF yield and efficiency.

Methods: We compared the yield and efficiency of novel ICF algorithms inclusive of point-of-care CRP-based TB screening and confirmatory testing with urine TB-LAM (if CD4 count ≤100 cells/μl), sputum Xpert, and/or a single sputum culture among consecutive people living with HIV with CD4 counts less than or equal to 350 cells/μl initiating antiretroviral therapy in Uganda.

View Article and Find Full Text PDF

Background: Throughout the world, there are antiretroviral therapy-naive HIV+ individuals who maintain elevated peripheral CD4 T-cell counts, historically referred to as long-term nonprogressors (LTNPs). With recent improvements in viral load (VL) detection methods to levels as low as 20 copies per milliliter, 2 subsets of LTNPs have been defined: elite controllers (ECs), with undetectable VLs for at least 6-12 months, and viremic controllers (VCs), with VLs between 200 and 2000 copies per milliliter. ECs and VCs have been extensively studied in the developed world to determine underlying mechanisms responsible for virologic control.

View Article and Find Full Text PDF

Objective: To assess the comparative effectiveness of alternative incentive-based interventions to promote HIV testing among men.

Design: Randomized clinical trial.

Methods: We enumerated four Ugandan parishes and enrolled men at least 18 years.

View Article and Find Full Text PDF

Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya.

J Clin Tuberc Other Mycobact Dis

December 2017

University of California, San Francisco, Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, San Francisco, USA.

Background: Reducing tuberculosis (TB) deaths among children requires a better understanding of the gaps in the care cascade from TB diagnosis to treatment completion. We sought to assess the child TB care cascade in 32 rural communities in Uganda and Kenya using programmatic data.

Methods: This is a retrospective cohort study of 160,851 children (ages <15 years) living in 12 rural communities in Kenya and 22 in Uganda.

View Article and Find Full Text PDF

Introduction: The concept of "therapeutic citizenship" has drawn attention to ways in which public testimony, the "story-telling in the public sphere" undertaken by people living with HIV (PLHIV), has shaped the global response to the epidemic. This paper presents qualitative findings from two large studies in eastern Africa that reveal how the advent of population-based HIV testing campaigns and efforts to accelerate antiretroviral "treatment for all" has precipitated a rapidly expanding therapeutic citizenship "project," or social movement. The title of this paper refers to Goffman's original conceptualization of stigma as a social process through which a person's identity is rendered "spoiled.

View Article and Find Full Text PDF

Introduction: The Streamlined Antiretroviral Therapy Initiation Strategy (START-ART) study found that a theory-based intervention using opinion leaders to inform and coach health care providers about the risks of treatment delay, provision of point of care (POC) CD4 testing machines (PIMA) and reputational incentives, led to rapid rise in ART initiation. We used qualitative research methods to explore mechanisms of provider behaviour change.

Methods: We conducted in-depth interviews (IDIs) with 24 health care providers and nine study staff to understand perceptions, attitudes and the context of changes in ART initiation practices.

View Article and Find Full Text PDF

The authors sought to describe the association between human immunodeficiency virus (HIV) and blood pressure (BP) levels, and determined the extent to which this relationship is mediated by body weight in a cross-sectional study of HIV-infected and HIV-uninfected controls matched by age, sex, and neighborhood. Mixed-effects models were fit to determine the association between HIV and BP and amount of effect of HIV on BP mediated through body mass index. Data were analyzed from 577 HIV-infected and 538 matched HIV-uninfected participants.

View Article and Find Full Text PDF

Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.

J Acquir Immune Defic Syndr

December 2017

*Stanford University School of Medicine, Stanford, CA †Infectious Diseases Research Collaboration, Kampala, Uganda ‡Kenya Medical Research Institute, Nairobi, Kenya §Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA ‖Makerere University Joint AIDS Program, Kampala, Uganda ¶Makerere University College of Health Sciences, School of Medicine, Kampala, Uganda #University of California, Berkeley School of Public Health, Berkeley, CA.

View Article and Find Full Text PDF

Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.

Lancet Infect Dis

December 2017

Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA; Curry International Tuberculosis Center, University of California, San Francisco, Oakland, CA, USA.

Background: Symptom-based screening for tuberculosis is recommended for all people living with HIV. This recommendation results in unnecessary Xpert MTB/RIF testing in many individuals living in tuberculosis-endemic areas and thus poor implementation of intensified case finding and tuberculosis preventive therapy. Novel approaches to tuberculosis screening are needed to help achieve global targets for tuberculosis elimination.

View Article and Find Full Text PDF

Background: The prevalence of HIV in Uganda is 7.3%, and yet nearly 40% of people living with HIV are unaware of their status. The current HIV testing policy which is strictly blood-based poses several challenges including: a need for high level laboratory skills, stringent waste disposal needs, and painful sample collection.

View Article and Find Full Text PDF

Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.

J Acquir Immune Defic Syndr

September 2017

*Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA †Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA ‡Kenya Medical Research Institute, Kisumu, Kenya §Infectious Diseases Research Collaboration, Kampala, Uganda ‖Division of HIV Prevention, Makerere University Joint AIDS Program, Kampala, Uganda ¶Department of Pediatrics, Division of Infectious Diseases, University of California San Francisco, San Francisco, CA #Department of Obstetrics, Gynecology and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA **Makerere University College of Health Sciences, School of Medicine, Kampala, Uganda ††Division of Biostatistics and Epidemiology, University of California Berkeley, Berkeley, CA.

View Article and Find Full Text PDF

Background: Couple HIV Counseling and Testing (CHCT) is one of the key preventive strategies used to reduce the spread of HIV. In Uganda, HIV prevalence among married/living together is 7.2% among women and 7.

View Article and Find Full Text PDF

Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.

J Acquir Immune Defic Syndr

November 2016

*Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA; †Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA; ‡School of Economics, University of Nairobi, Nairobi, Kenya; §Gillings School of Global Public Health, University of North Carolina at Chapel Hill, NC; ‖Center for AIDS Prevention Studies, University of California, San Francisco, CA; ¶Department of Biostatistics, University of California, Berkeley, CA; #Infectious Disease Research Collaboration, Kampala, Uganda; **Kenya Medical Research Institute, Nairobi, Kenya; ††Division of HIV Prevention, Makerere University Joint AIDS Program, Kampala, Uganda; ‡‡Department of Obstetrics, Gynecology and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California, San Francisco, CA; and §§Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Background: In 2013-2014, we achieved 89% adult HIV testing coverage using a hybrid testing approach in 32 communities in Uganda and Kenya (SEARCH: NCT01864603). To inform scalability, we sought to determine: (1) overall cost and efficiency of this approach; and (2) costs associated with point-of-care (POC) CD4 testing, multidisease services, and community mobilization.

Methods: We applied microcosting methods to estimate costs of population-wide HIV testing in 12 SEARCH trial communities.

View Article and Find Full Text PDF

High levels of retention in care with streamlined care and universal test and treat in East Africa.

AIDS

November 2016

aDivision of HIV, ID and Global Medicine bCenter for AIDS Prevention Studies, University of California, San Francisco, San Francisco, California, USA cKenya Medical Research Institute, Kwale, Kenya dInfectious Diseases Research Collaboration eDivision of HIV Prevention, Makerere University Joint AIDS Program, Kampala, Uganda fDepartment of Pediatrics, Division of Infectious Diseases gDepartment of Obstetrics, Gynecology & Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, California, USA hSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda iDivision of Biostatistics and Epidemiology, University of California, Berkeley, Berkeley, California, USA.

Objective: We sought to measure retention in care and identify predictors of nonretention among patients receiving antiretroviral therapy (ART) with streamlined delivery during the first year of the ongoing Sustainable East Africa Research on Community Health (SEARCH) 'test-and-treat' trial (NCT 01864603) in rural Uganda and Kenya.

Design: Prospective cohort of patients in the intervention arm of the SEARCH study.

Methods: We measured retention in care at 12 months among HIV-infected adults who linked to care and were offered ART regardless of CD4 cell count, following community-wide HIV-testing.

View Article and Find Full Text PDF

Men's uptake of HIV testing is critical to the success of "test and treat" strategies in generalized epidemics. This study sought to identify cultural factors and community processes that influence men's HIV testing uptake in the baseline year of an ongoing test-and-treat trial among 334,479 persons in eastern Africa (SEARCH, NCT#01864603). Data were collected using participant observation at mobile community health campaigns (CHCs) (n = 28); focus group discussions (n = 8 groups) with CHC participants; and in-depth interviews with care providers (n = 50), leaders (n = 32), and members (n = 112) of eight communities in Kenya and Uganda.

View Article and Find Full Text PDF

People living with HIV/AIDS anticipate HIV-related stigma and fear disclosure to intimate partners. Yet, disclosure is critical to reducing HIV transmission and improving care engagement. This qualitative study characterized HIV disclosure experiences and normative beliefs among couples in communities participating in an HIV test-and-treat trial in Kenya and Uganda (Sustainable East Africa Research in Community Health, NCT#01864603).

View Article and Find Full Text PDF

Introduction: Diagnostic guidelines for Tuberculosis (TB) in HIV infected patients previously relied on microscopy where the value of initial antibiotic treatment for exclusion of pulmonary TB (PTB) was limited. New guidelines rely on the Xpert MTB Rif test (Xpert). However, the value of the antibiotic treatment remains unclear particularly in individuals who are smear-negative and Xpert-negative-given Xpert has only moderate sensitivity for smear-negative PTB.

View Article and Find Full Text PDF